Rifampicin hepatitis. A clinical and histological study.
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000175:diagnosis / Q000473:pathology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D013194:Staining and Labeling; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D011239:Prednisolone; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin